Do you still think Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is worth a look?
In Thursday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $5.50, up 3.38% from the previous session. RXRX stock price is now -18.24% away from the 50-day moving average and -20.49% away from the 200-day moving average. The market capitalization of the company currently stands at $2.21B. With the price target of $8, […]
Why Recursion Pharmaceuticals Inc (RXRX) Should Be On Your Radar Moving Forward
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded -4.34% lower at $5.51 on Wall Street last session. RXRX stock price is now -19.60% away from the 50-day moving average and -20.70% away from the 200-day moving average. The market capitalization of the company currently stands at $2.21B. With the price target of $8, Morgan Stanley recently initiated […]
A breakdown of the latest mutual funds holding Recursion Pharmaceuticals Inc (RXRX)
In Tuesday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $3.97, down -5.48% from the previous session. RXRX stock price is now -43.57% away from the 50-day moving average and -43.51% away from the 200-day moving average. The market capitalization of the company currently stands at $1.60B. With the price target of $8, […]
Could Recursion Pharmaceuticals Inc (RXRX) stock price achieve new all-time highs if its expected earnings and revenue increase?
In Monday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $5.29, down -8.95% from the previous session. RXRX stock price is now -27.92% away from the 50-day moving average and -26.23% away from the 200-day moving average. The market capitalization of the company currently stands at $2.13B. With the price target of $8, […]
Does Recursion Pharmaceuticals Inc (NASDAQ:RXRX) warrant a purchase right now? What to Consider Before Making a Decision
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded 3.09% higher at $6.68 on Wall Street last session. RXRX stock price is now -9.83% away from the 50-day moving average and -7.85% away from the 200-day moving average. The market capitalization of the company currently stands at $2.69B. With the price target of $8, Morgan Stanley recently initiated […]
Recursion Pharmaceuticals Inc (RXRX) – it’s time to buy. Check out key Indicators
Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, up 7.72% to $6.84. RXRX stock price is now -8.73% away from the 50-day moving average and -6.17% away from the 200-day moving average. The market capitalization of the company currently stands at $2.75B. With the price target of $8, Morgan Stanley […]
Recursion Pharmaceuticals Inc (RXRX) Price Aside, RXRX Fundamentals Booming Beyond Compare
In Monday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $6.13, down -6.98% from the previous session. RXRX stock price is now -19.17% away from the 50-day moving average and -16.75% away from the 200-day moving average. The market capitalization of the company currently stands at $2.46B. With the price target of $8, […]
Before You Invest In Recursion Pharmaceuticals Inc (NASDAQ:RXRX), Consider This Metric
Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, up 2.46% to $8.34. RXRX stock price is now 9.96% away from the 50-day moving average and 11.62% away from the 200-day moving average. The market capitalization of the company currently stands at $3.26B. With the price target of $8, Morgan Stanley […]
How should investors evaluate Recursion Pharmaceuticals Inc (NASDAQ:RXRX)?
Stocks of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) traded higher last session on Wall Street, down -3.02% to $9.00. RXRX stock price is now 19.12% away from the 50-day moving average and 20.38% away from the 200-day moving average. The market capitalization of the company currently stands at $3.52B. With the price target of $8, Morgan Stanley […]
Before You Invest In Recursion Pharmaceuticals Inc (NASDAQ:RXRX), Consider This Metric
In Tuesday’s Wall Street session, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares traded at $10.64, up 1.04% from the previous session. RXRX stock price is now 44.46% away from the 50-day moving average and 42.75% away from the 200-day moving average. The market capitalization of the company currently stands at $4.16B. With the price target of $8, […]